Beijing Chunlizhengda Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of surgical impl...
Chunlizhengda Confirms Valid 2025 AGM and A-Shareholder Meeting Votes
Beijing Chunlizhengda Sets Final Dividend and Clarifies H-Share Tax Treatment
Beijing Chunlizhengda Sets Final 2025 Dividend, Clarifies Withholding Tax Rules
Over Half of Listed Chinese Drugmakers See 2025 Profit Grow Buoyed by Innovative Medicines, Overseas Business
"Performance" Chunli Medical's annual net profit is 273 million RMB, an increase of 118%, with earnings per share of 0.15 RMB
"Performance" Chunli Medical's annual net profit is 272 million RMB, an increase of 117.7%